New Hope for Enlarged Prostate: Avant Enrolls World’s First Patient in the ProVIDE Clinical Trial

For those suffering from benign prostatic hyperplasia (BPH) – more commonly known as ‘Enlarged Prostate’ – life can be far from comfortable. But once again on the cutting-edge of medical advances and technologies, Avant Concierge Urology just made global history as the first doctor’s office to join the clinical trial for the ProVee System, a nitinol expander designed to gently re-shape the enlarged prostate and alleviate the symptoms caused by BPH. 

Earlier this week, Avant Medical Director Dr. Sijo Parekattil successfully performed the first procedure for the clinical trial in his Florida-based office.

“The ProVee procedure is straightforward and comfortably performed in a doctor’s office. I see many patients whose quality of life is adversely impacted by the symptoms associated with an enlarged prostate, so the ProVee System represents an exciting new alternative for BPH treatment.”

In testing the procedure, the ProVIDE pivotal clinical trial is officially underway to evaluate the safety and effectiveness of the system, sponsored by ProVerum Limited, an Irish medical device company developing a minimally invasive solution to BPH in doctor’s office settings.

As explained by ProVerum, ProVee is a ‘stent-like’ expander designed to gently open up the obstructed urethra without heating, piercing, cutting, or removing part of the prostate. The delivery system for the expander is thinner than most currently available BPH treatment options, and the uncomplicated procedure is intended to be performed in an outpatient or doctor’s office setting.

Known worldwide as a leader in robotic-assisted microsurgery, Dr. Parekattil and his colleagues at Avant Concierge Urology utilize the latest and most advanced technologies to treat patients. In fact, Dr. Parekattil is one of the founding Board members of the Robotic Assisted Microsurgical & Endoscopic Society (RAMSES). One of the defining characteristics of Avant Concierge Urology is the practice’s focus on bringing the latest and best-in-class technology to patients. When dreaming up Avant, Dr. Parekattil knew that he wanted to establish surgical suites unlike any others across the globe. 

Steve Kaplan, M.D., Professor of Urology at the Icahn School of Medicine at Mount Sinai in New York is the Global Lead Investigator for the ProVIDE study. 

“The ProVee System has the potential to be an effective treatment for BPH that can be safely and reliably performed in the office setting,” stated Dr. Kaplan. “This international, multi-center clinical study will thoroughly evaluate the safety, efficacy, and long-term durability of the ProVee device, and I look forward to presenting the data from this large controlled clinical trial.”

To learn more about Avant Concierge Urology or to inquire about potentially enrolling in the ProVee System clinical trial with Dr. Sijo Parekattil and ProVerum Limited, call +1- 407-547-1654 or fill out the Contact Us form on the Avant website.

Leave a Reply

Your email address will not be published. Required fields are marked *